| 摘要 |
<p>The present invention describes novel oral dosage comprising composition of antioxidant, preferably Factor Alpha tx and vitamin C with other anti-tubercular drugs such as Rifampicin, lsoniazid, Pyrazinamide and Ethambutol to treat patients with tuberculosis, more particularly pulmonary tuberculosis. More particularly present invention describes oral dosages comprising synergistic composition in combination or as a combipack of individual anti-tubercular drugs such as Rifampicin, lsoniazid, Pyrazinamide and Ethambutol with Factor Alpha tx and vitamin C useful in the treatment of pulmonary tuberculosis.</p> |
